Molecular Diagnostics

Venue: London

Location: London, United Kingdom

Event Date/Time: Jun 07, 2004 End Date/Time: Jun 08, 2004
Report as Spam


Molecular diagnostics has progressed from a labour-intensive, tiny niche market to one that is increasingly the object of automation and represents upwards of ten percent of the total in vitro diagnostics reagent and equipment marketplace. Molecular infectious disease diagnostics dominates, but applications to new areas of pathology continue to proliferate. The medical interest in nucleic acids is about to enter a new era as DNA and RNA are being thought of more and more as objects of therapy. The days of molecular pharmacology and pharmacogenomics are upon us.

This conference is unique in presenting a surprisingly comprehensive, yet succinct program that will touch on all of these subjects from medical, practical, and economic points of view. Join in; it promises not to disappoint.

Attend this conference and meet and benchmark with an impressive group of international experts who are applying and developing molecular diagnostics today, including speakers from:
Novartis, Roche Diagnostics, ARUP Laboratories, Abbott Molecular Diagnostics, Gendia, Bayer Healthcare, Quest Diagnostics, Vysis, Inc.
Benefit from their up-to-the-minute research, results and insights into:

- Challenges to marketing, commercialisation and acceptance of molecular diagnostics
- Approaching performance, validation and standardisation of tests for infectious diseases
- Viral load quantitation and genotyping with real-time PCR
- Using molecular diagnostics for disease prediction and assessing therapy responses
- Clinical utility of molecular diagnostics in pharmacogenetics
- Application of array CGH in clinical genetics
- Disease susceptibility and diagnosis of inherited disease